Cargando…

Diverse and converging roles of ERK1/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer

The epithelial to mesenchymal transition (EMT) is characterized by a loss of cell polarity, a decrease in the epithelial cell marker E-cadherin, and an increase in mesenchymal markers including the zinc-finger E-box binding homeobox (ZEB1). The EMT is also associated with an increase in cell migrati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhatt, Akshita B., Wright, Thomas D., Barnes, Van, Chakrabarty, Suravi, Matossian, Margarite D., Lexner, Erin, Ucar, Deniz A., Miele, Lucio, Flaherty, Patrick T., Burow, Matthew E., Cavanaugh, Jane E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020482/ https://www.ncbi.nlm.nih.gov/pubmed/33761370 http://dx.doi.org/10.1016/j.tranon.2021.101046

Ejemplares similares

Molecular Mechanisms of Epithelial to Mesenchymal Transition Regulated by ERK5 Signaling
por: Bhatt, Akshita B., et al.
Publicado: (2021)

ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer
por: Hoang, Van T., et al.
Publicado: (2020)

Novel Diphenylamine Analogs Induce Mesenchymal to Epithelial Transition in Triple Negative Breast Cancer
por: Bhatt, Akshita B., et al.
Publicado: (2019)

Constitutive activation of MEK5 promotes a mesenchymal and migratory cell phenotype in triple negative breast cancer
por: Matossian, Margarite D., et al.
Publicado: (2021)

Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor
por: Chang, Tiffany C., et al.
Publicado: (2020)

Correction: Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor
por: Chang, Tiffany C., et al.
Publicado: (2021)

Notch Signaling Regulates Mitochondrial Metabolism and NF-κB Activity in Triple-Negative Breast Cancer Cells via IKKα-Dependent Non-canonical Pathways
por: Hossain, Fokhrul, et al.
Publicado: (2018)

Targeting Mcl-1 by a small molecule NSC260594 for triple-negative breast cancer therapy
por: Dong, Shengli, et al.
Publicado: (2023)

Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model
por: Matossian, Margarite D., et al.
Publicado: (2018)

Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer
por: Hossain, Fokhrul, et al.
Publicado: (2023)

Convergence of BMI1 and CHD7 on ERK Signaling in Medulloblastoma
por: Badodi, Sara, et al.
Publicado: (2017)

Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells
por: Matossian, Margarite D., et al.
Publicado: (2021)

Ceritinib is a novel triple negative breast cancer therapeutic agent
por: Dong, Shengli, et al.
Publicado: (2022)

Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models
por: Sabol, Rachel A., et al.
Publicado: (2019)

Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer
por: Matossian, Margarite D., et al.
Publicado: (2020)

Evaluation of liver kinase B1 downstream signaling expression in various breast cancers and relapse free survival after systemic chemotherapy treatment
por: Nguyen, Khoa, et al.
Publicado: (2021)

Phosphorylation of ERK5 on Thr732 Is Associated with ERK5 Nuclear Localization and ERK5-Dependent Transcription
por: Honda, Takuto, et al.
Publicado: (2015)

Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse
por: Cahill, Emma, et al.
Publicado: (2014)

Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
por: Matossian, Margarite D., et al.
Publicado: (2019)

Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes
por: Matossian, Margarite D., et al.
Publicado: (2017)

ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft models
por: Guo, Shanchun, et al.
Publicado: (2018)

S-nitrosylation of ERK inhibits ERK phosphorylation and induces apoptosis
por: Feng, Xiujing, et al.
Publicado: (2013)

KSR1- and ERK-dependent translational regulation of the epithelial-to-mesenchymal transition
por: Rao, Chaitra, et al.
Publicado: (2021)

NMDA and Dopamine Converge on the NMDA-Receptor to Induce ERK Activation and Synaptic Depression in Mature Hippocampus
por: Kaphzan, Hanoch, et al.
Publicado: (2006)

The N-Terminal Domain of ERK1 Accounts for the Functional Differences with ERK2
por: Marchi, Matilde, et al.
Publicado: (2008)

ERK signalling modulates epigenome to drive epithelial to mesenchymal transition
por: Navandar, Mohit, et al.
Publicado: (2017)

Quantifying Breast Cancer-Driven Fiber Alignment and Collagen Deposition in Primary Human Breast Tissue
por: Gurrala, Rakesh, et al.
Publicado: (2021)

Isoform-Specific Roles of ERK1 and ERK2 in Arteriogenesis
por: Ricard, Nicolas, et al.
Publicado: (2019)

ERK1 and ERK2 present functional redundancy in tetrapods despite higher evolution rate of ERK1
por: Buscà, Roser, et al.
Publicado: (2015)

PI3K-dependent cross-talk interactions converge with Ras as quantifiable inputs integrated by Erk
por: Wang, Chun-Chao, et al.
Publicado: (2009)

PI3K-dependent cross-talk interactions converge with Ras as quantifiable inputs integrated by Erk
por: Wang, Chun-Chao, et al.
Publicado: (2011)

Specifically targeting ERK1 or ERK2 kills Melanoma cells
por: Qin, Jianzhong, et al.
Publicado: (2012)

The role of ERK-1 and ERK-2 gene polymorphisms in PCOS pathogenesis
por: Guney, Gurhan, et al.
Publicado: (2022)

Liver Kinase B1 Regulates Remodeling of the Tumor Microenvironment in Triple-Negative Breast Cancer
por: King, Connor T., et al.
Publicado: (2022)

ERK1/2 inhibitors act as monovalent degraders inducing ubiquitylation and proteasome-dependent turnover of ERK2, but not ERK1
por: Balmanno, Kathryn, et al.
Publicado: (2023)

Water-pipe smoking promotes epithelial–mesenchymal transition and invasion of human breast cancer cells via ERK1/ERK2 pathways
por: Sadek, Khaled W., et al.
Publicado: (2018)

Conditional loss of ERK1 and ERK2 results in abnormal placentation and delayed parturition in the mouse
por: Brown, Jessica L., et al.
Publicado: (2019)

Time encoding by ERKs
por: Wells, William A.
Publicado: (2005)

Distinct functions for ERKs?
por: Lloyd, Alison C
Publicado: (2006)

Erk in Kidney Diseases
por: Feliers, Denis, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_t60hsggrhkeou8uab4571epstj